Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Clinicohematologic and Molecular Response of Essential Thrombocythemia Patients Treated with Pegylated Interferon-Alpha: A Multicenter Study on Behalf of the German Study Group-MPN (GSG-MPN)

Frank Stegelmann, Lino L. Teichmann, Florian H. Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, Andreas Reiter, Sara Otten, Stefanie Schauer, Ruth-Miriam Körber, Kim Kricheldorf, Susanne Isfort, Hartmut Döhner, Tim H. Brümmendorf, Martin Griesshammer, Konstanze Döhner, Steffen Koschmieder

Blood (2022) 140 (Supplement 1): 6874–6876.

https://doi.org/10.1182/blood-2022-165034

Published: 2022

Journal Articles

Response and Resistance to Cladribine in Patients with Advanced Systemic Mastocytosis: A Registry-Based Analysis

Johannes Lübke, Nicole Naumann, Sebastian Kreil, Georgia Metzgeroth, Hans-Peter Horny, Karl Sotlar, Nicholas C.P. Cross, Alice Fabarius, Peter Valent, Wolf-Karsten Hofmann, Juliana Schwaab, Andreas Reiter

Blood (2022) 140 (Supplement 1): 3970–3971.

https://doi.org/10.1182/blood-2022-163650

Published: 2022

Journal Articles

Antibody Response to Vaccination with BNT162b2, mRNA-1273, and ChADOx1 in Patients with Myeloid and Lymphoid Neoplasms

Jil Rotterdam, Margot Thiaucourt, Juliana Schwaab, Andreas Reiter, Sebastian Kreil, Laurenz Steiner, Henning D. Popp, Wolf-Karsten Hofmann, Karin Bonatz, Catharina Gerhards, Michael Neumaier, Mohamad Jawhar, Susanne Saussele

Blood (2021) 138 (Supplement 1): 218.

https://doi.org/10.1182/blood-2021-146832

Published: 2021

Journal Articles

KIT D816 Mutated / CBF-Negative Acute Myeloid Leukemia (AML): A New Poor-Risk Subtype Associated with Systemic Mastocytosis (SM-AML)

Blood (2018) 132 (Supplement 1): 1535.

https://doi.org/10.1182/blood-2018-99-115895

Published: 2018

Journal Articles

Systemic Mastocytosis with Associated Acute Myeloid Leukemia (SM-AML): a Poor-Risk Multi-Mutated Disease That Follows a Distinct Diagnostic Algorithm and Requires High-Dose Stem Cell-Targeting Therapy

Blood (2017) 130 (Supplement 1): 2916.

https://doi.org/10.1182/blood.V130.Suppl_1.2916.2916

Published: 2017

Journal Articles

The Impact of Colonization with Multidrug-Resistant Bacterial Pathogens (MRP) in Allogeneic Hematopoietic Cell Transplantation - Clearance of the MRP Is Pivotal for Survival

Daniela Heidenreich, Sebastian Kreil, Klaus-Peter Becker, Thomas Miethke, Wolf-Karsten Hofmann, MD, Stefan A. Klein, MD

Blood (2016) 128 (22): 3421.

https://doi.org/10.1182/blood.V128.22.3421.3421

Published: 2016

Journal Articles

Limited Efficacy of Ponatinib in Myeloproliferative Neoplasms Associated with FGFR1 Fusion Genes

Sebastian Kreil, MD PhD, Lionel Adès, MD PhD, Martin Bommer, MD, Frank Stegelmann, MD, Mark E Ethell, MBBChir, MA, FRCP, FRCPath, Anna Lubking, MD, Peter Martin, MD, Ekkehard Eigendorff, MD, Wolf-Karsten Hofmann, MD, Nicholas C.P. Cross, PhD, Andreas Hochhaus, MD, Andreas Reiter, MD

Blood (2015) 126 (23): 2812.

https://doi.org/10.1182/blood.V126.23.2812.2812

Published: 2015

Journal Articles

Influence of the Insertion Site on Central Venous Catheter Related Complications in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation, High Dose Therapy or Induction Therapy for Acute Leukemia

Daniela Heidenreich, Eleonore Muetzel, Sebastian Kreil, Florian Nolte, Melanie Faust, Mohamad Jawhar, Anna Hecht, Wolf-Karsten Hofmann, Stefan A. Klein

Blood (2015) 126 (23): 1919.

https://doi.org/10.1182/blood.V126.23.1919.1919

Published: 2015

Journal Articles

Multidrug-Resistant Bacterial Pathogens in Allogeneic Hematopoietic Cell Transplantation - a Retrospective Single Center Analysis

Daniela Heidenreich, Florian Nolte, Sebastian Kreil, Marc Reinwald, Wolf-Karsten Hofmann, Stefan A. Klein

Blood (2014) 124 (21): 3888.

https://doi.org/10.1182/blood.V124.21.3888.3888

Published: 2014

Journal Articles

Allogeneic Hematopoietic Cell Transplantation Is Effective In Patients With Advanced Systemic Mastocytosis: A Multicenter Retrospective Analysis

Blood (2013) 122 (21): 2145.

https://doi.org/10.1182/blood.V122.21.2145.2145

Published: 2013

Journal Articles

Identification of Characteristic Findings by Abdominal Magnetic Resonance Imaging in Acute Intestinal Graft Versus Host Disease

Stefan A. Klein, Johannes Budjan, Daniela Heidenreich, Ulrike Attenberger, Sebastian Kreil, Stefan Schönberg, Wolf-Karsten Hofmann, Henrik J. Michaely

Blood (2012) 120 (21): 4170.

https://doi.org/10.1182/blood.V120.21.4170.4170

Published: 2012

Journal Articles

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms

Francis H. Grand, Claire E. Hidalgo-Curtis, Thomas Ernst, Katerina Zoi, Christine Zoi, Carolann McGuire, Sebastian Kreil, Amy Jones, Joannah Score, Georgia Metzgeroth, David Oscier, Andrew Hall, Christian Brandts, Hubert Serve, Andreas Reiter, Andrew J. Chase, Nicholas C. P. Cross

Blood (2009) 113 (24): 6182–6192.

https://doi.org/10.1182/blood-2008-12-194548

Published: 2009

Journal Articles

Frequent CBL Mutations Associated with 11q Acquired Uniparental Disomy in Myeloproliferative Neoplasms

Francis Grand, PhD, Claire Hidalgo-Curtis, BSc, Thomas Ernst, MD, Katerina Zoi, PhD, Christine Zoi, MD, Carolann McGuire, PhD, Sebastian Kreil, MD, Georgia Metzgeroth, MD, David Oscier, MD, Andrew Hall, PhD, Christian Brandts, MD, Hubert Serve, Andreas Reiter, MD, Andrew Chase, PhD, Nicholas C.P. Cross, PhD

Blood (2008) 112 (11): 174.

https://doi.org/10.1182/blood.V112.11.174.174

Published: 2008

Journal Articles

Association between Polymorphic Variation at the IL5RA Locus and the Severity of FIP1L1-PDGFRA Positive Chronic Eosinophilic Leukaemia

Sonja Burgstaller, MD, Sebastian Kreil, MD, Katherine Waghorn, BSc, Georgia Metzgeroth, MD, Claude Preudhomme, PhD, Katerina Zoi, PhD, Helen White, PhD, Daniela Cilloni, PhD, Christine Zoi, MD, Finella Brito-Babapulle, MD, Christoph Walz, MD, Andreas Reiter, MD, Nicholas C.P. Cross, PhD

Blood (2007) 110 (11): 1544.

https://doi.org/10.1182/blood.V110.11.1544.1544

Published: 2007

Journal Articles

Polymorphic Variation at the STAT5 Locus Is Associated with the Response of CML Patients to Interferon Alpha.

Sebastian Kreil, MD, Katherine Waghorn, BSc, Rudiger Hehlmann, MD, Andreas Reiter, MD, PhD, Andreas Hochhaus, MD, PhD, Nicholas C.P. Cross, PhD

Blood (2007) 110 (11): 2913.

https://doi.org/10.1182/blood.V110.11.2913.2913

Published: 2007

Journal Articles

Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia

Sebastian Kreil, Markus Pfirrmann, Claudia Haferlach, Katherine Waghorn, Andrew Chase, Rüdiger Hehlmann, Andreas Reiter, Andreas Hochhaus, Nicholas C. P. Cross

Blood (2007) 110 (4): 1283–1290.

https://doi.org/10.1182/blood-2007-02-074252

Published: 2007

Includes: Supplemental data

Journal Articles

Heterogeneous Prognostic Impact of 9q+ Deletions in Patients with Chronic Myelogenous Leukemia.

Sebastian Kreil, MD, Katherine Waghorn, Markus Pfirrmann, MSc, Andreas Reiter, MD, Rudiger Hehlmann, MD, Andreas Hochhaus, MD, Nicholas C.P. Cross, PhD

Blood (2006) 108 (11): 2111.

https://doi.org/10.1182/blood.V108.11.2111.2111

Published: 2006

Journal Articles

Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha

Amy V. Jones, Richard T. Silver, Katherine Waghorn, Claire Curtis, Sebastian Kreil, Katerina Zoi, Andreas Hochhaus, David Oscier, Georgia Metzgeroth, Eva Lengfelder, Andreas Reiter, Andrew J. Chase, Nicholas C. P. Cross

Blood (2006) 107 (8): 3339–3341.

https://doi.org/10.1182/blood-2005-09-3917

Published: 2006

Journal Articles

No Significant Molecular Response in Polycythemia Vera Patients Treated with Imatinib or Interferon alpha.

Amy V. Jones, BSc, Katherine Higley, BSc, Claire Curtis, BSc, Sebastian Kreil, MD, Katerina Zoi, MSc, Andreas Hochhaus, MD, Andreas Reiter, MD, David Oscier, MD, Alec Merber, BSc, Richard T. Silver, MD, Nicholas C.P. Cross, PhD

Blood (2005) 106 (11): 373.

https://doi.org/10.1182/blood.V106.11.373.373

Published: 2005

Journal Articles

Early Detection of Imminent Hematologic Relapse Due to BCR-ABL Kinase Domain Mutations in CML Patients on Imatinib Therapy by D-HPLC.

Thomas Ernst, MD, Philipp Erben, MD, Thomas Schenk, MD, Martin C. Mueller, MD, Michael Emig, MD, Sebastian Kreil, MD, Paul La Rosée, MD, Ute Berger, MD, Ruediger Hehlmann, MD, Andreas Hochhaus, MD

Blood (2005) 106 (11): 1088.

https://doi.org/10.1182/blood.V106.11.1088.1088

Published: 2005

NARROW

Clinicohematologic and Molecular Response of Essential Thrombocythemia Patients Treated with Pegylated Interferon-Alpha: A Multicenter Study on Behalf of the German Study Group-MPN (GSG-MPN)

Response and Resistance to Cladribine in Patients with Advanced Systemic Mastocytosis: A Registry-Based Analysis

Antibody Response to Vaccination with BNT162b2, mRNA-1273, and ChADOx1 in Patients with Myeloid and Lymphoid Neoplasms

KIT D816 Mutated / CBF-Negative Acute Myeloid Leukemia (AML): A New Poor-Risk Subtype Associated with Systemic Mastocytosis (SM-AML)

Systemic Mastocytosis with Associated Acute Myeloid Leukemia (SM-AML): a Poor-Risk Multi-Mutated Disease That Follows a Distinct Diagnostic Algorithm and Requires High-Dose Stem Cell-Targeting Therapy

The Impact of Colonization with Multidrug-Resistant Bacterial Pathogens (MRP) in Allogeneic Hematopoietic Cell Transplantation - Clearance of the MRP Is Pivotal for Survival

Limited Efficacy of Ponatinib in Myeloproliferative Neoplasms Associated with FGFR1 Fusion Genes

Influence of the Insertion Site on Central Venous Catheter Related Complications in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation, High Dose Therapy or Induction Therapy for Acute Leukemia

Multidrug-Resistant Bacterial Pathogens in Allogeneic Hematopoietic Cell Transplantation - a Retrospective Single Center Analysis

Allogeneic Hematopoietic Cell Transplantation Is Effective In Patients With Advanced Systemic Mastocytosis: A Multicenter Retrospective Analysis

Identification of Characteristic Findings by Abdominal Magnetic Resonance Imaging in Acute Intestinal Graft Versus Host Disease

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms

Frequent CBL Mutations Associated with 11q Acquired Uniparental Disomy in Myeloproliferative Neoplasms

Association between Polymorphic Variation at the IL5RA Locus and the Severity of FIP1L1-PDGFRA Positive Chronic Eosinophilic Leukaemia

Polymorphic Variation at the STAT5 Locus Is Associated with the Response of CML Patients to Interferon Alpha.

Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia

Heterogeneous Prognostic Impact of 9q+ Deletions in Patients with Chronic Myelogenous Leukemia.

Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha

No Significant Molecular Response in Polycythemia Vera Patients Treated with Imatinib or Interferon alpha.

Early Detection of Imminent Hematologic Relapse Due to BCR-ABL Kinase Domain Mutations in CML Patients on Imatinib Therapy by D-HPLC.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only